Technology
Health
Biotechnology

Trevena

$1.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.60%) Today
+$0.01 (0.54%) After Hours

Why Robinhood?

You can buy or sell Trevena and other stocks, options, ETFs, and crypto commission-free!

About

Trevena, Inc. Common Stock, also called Trevena, is a biopharmaceutical company, which focuses on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS. Read More The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.

Employees
29
Headquarters
Chesterbrook, Pennsylvania
Founded
2007
Market Cap
154.77M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.58M
High Today
$2.00
Low Today
$1.79
Open Price
$1.90
Volume
2.15M
52 Week High
$3.58
52 Week Low
$0.3823

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Healthcare
Pharmaceutical
2014 IPO

News

Yahoo Finance14h

Will Trevena Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Trevena, Inc. TRVN. The stock has moved higher by 31.5% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path. We certainly think that this might be the case, particularly if you consider TRVN’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as TRVN has ea...

1,345
Yahoo FinanceMar 19

Watch These Four Healthcare Stocks Set The Pace On Tuesday

CORAL GABLES, FL/ ACCESSWIRE / March 19, 2019 / In the last few months, the healthcare stock market has responded favorably to the fact that the healthcare industry is one of the fastest changing sectors in the global marketplace.

1,461
Yahoo FinanceMar 18

Is Trevena (TRVN) Stock Outpacing Its Medical Peers This Year?

Investors focused on the Medical space have likely heard of Trevena (TRVN), but is the stock performing well in comparison to the rest of its sector peers?

1,225

Earnings

-$0.36
-$0.26
-$0.16
-$0.06
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.08 per share
Actual
-$0.10 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.